Aterian (NASDAQ:ATER) Cut to “Sell” at Wall Street Zen

Aterian (NASDAQ:ATER) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday.

Separately, Weiss Ratings upgraded Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, May 19th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Aterian presently has an average rating of “Sell”.

Aterian Stock Performance

Shares of NASDAQ:ATER opened at $0.40 on Friday. The company has a 50 day moving average price of $1.18 and a two-hundred day moving average price of $0.88. The company has a market capitalization of $4.36 million, a PE ratio of -0.16 and a beta of 0.68. Aterian has a 52 week low of $0.40 and a 52 week high of $1.87.

Aterian (NASDAQ:ATER) last announced its quarterly earnings results on Friday, May 15th. The company reported ($0.39) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.69) by $0.30. The company had revenue of $0.02 million during the quarter, compared to analyst estimates of $15.82 million. Aterian had a negative net margin of 39.56% and a negative return on equity of 82.05%.

Institutional Investors Weigh In On Aterian

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. XTX Topco Ltd acquired a new stake in Aterian during the 2nd quarter valued at $55,000. Goldman Sachs Group Inc. lifted its stake in shares of Aterian by 73.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock worth $45,000 after buying an additional 9,026 shares during the last quarter. Susquehanna International Group LLP boosted its holdings in shares of Aterian by 310.2% during the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock worth $43,000 after buying an additional 30,637 shares during the period. Finally, Citadel Advisors LLC grew its stake in Aterian by 222.0% in the 3rd quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock valued at $35,000 after buying an additional 22,865 shares during the last quarter. 7.02% of the stock is owned by institutional investors.

Aterian Company Profile

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.